Email Updates

You are here

Home

13 JULY 2018 VOLUME 19 ISSUE 28

Media Coverage

  • To end the world’s deadliest diseases, invest in civil society

    When it comes to dealing with global health challenges, representatives of civil society may not always be the most popular people in the room as they press for prioritizing marginalized and stigmatized groups. Yet, they may be the most impactful in ensuring that progress is made. The fact is that in the fight against HIV/AIDS, tuberculosis (TB) and malaria, civil society is an instrumental partner in advocacy and implementation. This sometimes means that it has to show some muscle.

    July 13, 2018
    General
    Reuters

  • PrEP@Home Pilot Shows Monitoring PrEP Without Clinic Visit is Feasible and Acceptable

    A pilot project, PrEP@Home, reduced clinic visits to one a year and demonstrated that men who have sex with men in three US cities were able to carry out all necessary sampling for tests at home, finding the experience of using the PrEP@Home package acceptable, investigators report in the online edition of Clinical Infectious Diseases.

    July 12, 2018
    PrEP
    aidsmap

  • Uncertainty Over PEPFAR Support Prompts Concerns from HIV Advocates in Nigeria

    The country was left off the list in part as a “wake-up call” for its government and those engaged in addressing the epidemic in the country — a bid to make them question and examine why they were left out, said US Global AIDS Coordinator Deborah Birx, who leads PEPFAR. In addition, Nigeria wasn’t made a focus country, largely because PEPFAR doesn’t understand the breadth and depth of the epidemic, making it difficult to respond equitably, she said.

    July 12, 2018
    General
    Devex

  • PrEP pill to prevent HIV remains little known in France

    The AIDS Association of France has launched a nationwide campaign to raise awareness of PrEP, an antiviral drug that protects against HIV. Although little known in France, the medication has proven effective in countries like the US and UK.

    July 12, 2018
    PrEP
    France24

  • Government error identifies thousands of HIV patients

    The identities of thousands of Tennessee citizens with HIV was listed on a server that could be accessed by hundreds of employees due to an error by the government, a report stated.

    July 12, 2018
    General
    New York Post

  • Elton John and Prince Harry prepare to launch global coalition at international AIDS conference

    The Elton John AIDS Foundation (EJAF) and International AIDS Foundation (IAF) announced Thursday (July 12) that Sir Elton John and Prince Harry, the Duke of Sussex, will be launching a new global coalition focused on treating HIV infections in men at the 2018 International AIDS Conference. This coalition will be revealed in Amsterdam at the conference's Opening Plenary on July 24.

    July 12, 2018
    General
    Billboard

  • 'Innovative' Mobile HIV Test and Treat Clinic Launched in Pretoria

    An innovative mobile HIV Test and Treat Clinic to be put out on a six months pilot could encourage more people to know their HIV status and reduce problematic queues in public clinics.

    July 12, 2018
    Treatment
    IOL

  • 1,400 girls enrolled in HIV prevention initiative

    The United States Embassy together with the office of the First Lady will celebrate the enrolment of 1,400 girls into the Determined, Resilient, Empowered, AIDS-free, Mentored and Safe (DREAMS) programme. DREAMS Namibia is an initiative that empowers adolescent girls and young women to remain HIV-free and to fully achieve their potential.

    July 12, 2018
    General
    Namibia Economist

  • SPECT imaging finds a new role in HIV research

    An imaging technique that can assess immune system recovery in macaque monkeys with an HIV-like infection could have similar future applications for evaluating recovery in humans after HIV treatment, the National Institutes of Health has announced.

    July 12, 2018
    General
    Radiology Business

  • Trump drains HIV/AIDS funding to pay for child migrant detention

    The Trump administration is reportedly draining money from HIV treatment programmes in order to fund child migrant detention.

    July 11, 2018
    General
    PinkNews

  • Here Are All the Ways Science is Taking on HIV This Week

    HIV research has made two huge leaps, a groundbreaking vaccine trial and a team of researchers who have figured out how the virus hides in our bodies.

    July 11, 2018
    HIV Vaccine, Treatment
    Buzzfeed

  • Anthony Fauci, MD: Working to end HIV/AIDS

    In late spring of 1981, Anthony Fauci, MD, then a 40-year-old immunologist, was in his office at the National Institutes of Health (NIH) Clinical Center when a history-changing report came across his desk. The June 5 Morbidity and Mortality Weekly Report (MMWR) from what was then called the Centers for Disease Control documented Pneumocystis carinii pneumonia in 5 gay men presenting at 3 Los Angeles hospitals.

    July 11, 2018
    General
    JAMA

  • Criminalisation of homosexuality is setting back the global fight against HIV/AIDS

    The report, launched today by a cross-party group of UK parliamentarians on HIV and AIDS, warns that marginalised groups “risk falling behind in the HIV response” because of stigma. The No One Left Behind report highlights gaps in provisions for marginalised groups in middle income countries, as international donors are refocussing funding in poorer regions.

    July 11, 2018
    General
    PinkNews

  • San Francisco docs aren’t adequately conducting PrEP monitoring tests

    Notwithstanding its status as the nation’s premier promoter of Truvada as pre-exposure prophylaxis use, San Francisco is seeing its health care providers conduct insufficient screening tests for those going on and using PrEP, aidsmap reports.

    July 11, 2018
    PrEP
    POZ

  • Early HIV vaccine study raises hopes for ongoing larger trial

    Findings from an early Phase I/IIa primate and human trial of the so-called mosaic HIV vaccine showed encouraging signs of the vaccine’s ability to prompt an immune response to the virus and backed the ongoing human efficacy trial of the vaccine currently running in sub-Saharan Africa, MedPage Today reports.

    July 10, 2018
    HIV Vaccine
    POZ

  • Decentralising HIV diagnosis bears fruits

    “We can now more easily switch our clients from one drug to another. Once a client walks into our institution, we can quickly check for their viral load count level and take necessary intervention immediately,” says Leonard Nyakabau, a nurse and HIV focal person for Hauna district hospital in Manicaland.

    July 10, 2018
    Treatment
    Zimbabwe Herald

  • Why southern women are hit hardest by HIV

    Several structural barriers may explain the HIV epidemic among women in the American South, according to a study recently published online in AIDS Care. The study identified the following as barriers to HIV prevention and care: eligibility requirements for Medicaid and the AIDS Drug Assistance Program (ADAP), lack of health insurance, high incarceration rates, and inadequate transportation and health infrastructure.

    July 9, 2018
    General
    AIDS Reader

  • Surgeon who was denied disability insurance for taking PrEP tells his story

    Earlier this year, urology resident Dr. Philip Cheng appeared on the front page of the New York Times. Here was the headline: “He Took a Drug to Prevent AIDS. Then He Couldn't Get Disability Insurance.” In this Open Forum Infectious Diseases podcast, he tells us some more about himself and the events surrounding his decision.

    July 9, 2018
    General, PrEP
    The BodyPro

  • Novel HIV vaccine candidate is safe and induces immune response in healthy adults and monkeys

    New research shows that an experimental HIV-1 vaccine regimen is well-tolerated and generated comparable and robust immune responses against HIV in healthy adults and rhesus monkeys. Moreover, the vaccine candidate protected against infection with an HIV-like virus in monkeys.

    July 7, 2018
    HIV Vaccine
    Science Daily

  • A new step towards an HIV/AIDS vaccine

    A preventive vaccine is an essential part of the strategy to eradicate the HIV pandemic….Over the years, a multitude of vaccine methodologies have been tested, but few have progressed to efficacy trials and only one provided evidence for protection. Current HIV vaccine efficacy trials aim to improve on the success of the RV144 trial in Thailand, which showed a modest 31·2% protection.

    July 6, 2018
    HIV Vaccine
    Lancet

  • Rising risks: revealing the relationship between internet ‘hook-ups’, methamphetamine use, STIs and HIV in Bangkok

    New study maps HIV risk factors among men who have sex with men in Thailand, showing internet ‘hook-ups’, methamphetamine use and chemsex to be the new big drivers of HIV.

    July 6, 2018
    General
    Avert

  • Condom Efficacy May have been Underestimated, New CDC Study Suggests

    The new estimate by the US Centers for Disease Control and Prevention (CDC) finds that condoms, used 100% of the time, stop more than nine out of ten HIV infections. Two previous analyses, one published back in 1989 and the other in 2015 found that they only stopped seven out of ten infections.

    July 4, 2018
    Male and Female Condoms
    aidsmap

Published Research

Announcements